| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
532,319 |
219,783 |
$30.70M |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
411,318 |
159,108 |
$5.24M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
383,910 |
164,953 |
$4.67M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
996 |
964 |
$86K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,346 |
1,882 |
$60K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
211 |
198 |
$10K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
12 |
12 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
12 |
12 |
$1K |
| 87593 |
|
18 |
15 |
$526.35 |
| 87486 |
|
12 |
12 |
$249.52 |
| 87541 |
|
12 |
12 |
$249.52 |
| 87581 |
|
12 |
12 |
$249.52 |
| 87640 |
|
12 |
12 |
$249.52 |
| 80061 |
Lipid panel |
20 |
12 |
$155.32 |
| 83721 |
|
21 |
13 |
$110.50 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20 |
12 |
$81.28 |
| 82248 |
|
19 |
12 |
$48.98 |